High-value drug suspect faces raps for P1.2-M shabu | Inquirer News

High-value drug suspect faces raps for P1.2-M shabu

/ 11:06 AM July 04, 2018

NCRPO officials present to media on Wednesday, July 4, 2018, alleged illegal drugs seized from a high-value target in Pasig City. INQUIRER.NET / GABRIEL PABICO LALU

The Eastern Police District (EPD) is set to file charges against a high-value target who was caught with 34 sachets of shabu amounting to P1.2 million in an operation in Barangay Pineda, Pasig City, on Tuesday.

The suspect, Antonio Intalan, 49, and the alleged drugs were presented by National Capital Region Police Office (NCRPO) Director Chief Supt. Guillermo Eleazar and EPD Director Senior Supt. Bernabe Balba at a press conference on Wednesday.

Article continues after this advertisement

Intalan will face charges for violating sections of R.A. 9165 or the Comprehensive Dangerous Drugs Act of 2002.

FEATURED STORIES

According to the NCRPO, the operation along Old MRR Street in the barangay was launched after intelligence reports pointing to the activities of drug dealers.

A previous report said Intalan, a member of the Amin Buratong drug syndicate, was on list of the Top 10 high-value targets and had been arrested in 2013, 2014, and 2017. /cbb

Article continues after this advertisement

READ: Cops seize shabu worth P1.25M from suspect in Pasig drug bust

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Drug war, EPD, Metro Manila, NCRPO, Pasig City, shabu

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.